The Omnipod Insulin Management System represents Insulet's core business segment, focusing on the development, manufacturing, and commercialization of tubeless insulin delivery technology. This system offers a unique approach to insulin therapy, eliminating the need for traditional tubing and simplifying the lives of individuals with insulin-dependent diabetes. Research and development efforts are continuously directed towards enhancing the Omnipod's features, improving its accuracy, and expanding its compatibility with various glucose monitoring systems. The Omnipod system directly impacts patient outcomes by providing a more convenient and discreet method of insulin delivery, leading to improved glycemic control and enhanced quality of life. Insulet maintains a strong market position in the insulin pump industry, driven by the innovative design and user-friendly nature of the Omnipod system. Future opportunities include expanding the system's capabilities through integration with advanced algorithms and connectivity solutions, further solidifying Insulet's leadership in diabetes management.